Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review
出版年份 2023 全文链接
标题
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review
作者
关键词
-
出版物
BIODRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-02
DOI
10.1007/s40259-023-00632-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle
- (2023) Adrien Morin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dystrophin Immunity after Gene Therapy for Duchenne’s Muscular Dystrophy
- (2023) Carsten G. Bönnemann et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR‒Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein
- (2023) Tatiana V. Egorova et al. Molecular Therapy-Methods & Clinical Development
- Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy
- (2022) Nathalie Bourg et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression
- (2022) Anna V. Starikova et al. Scientific Reports
- Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
- (2022) Arianna Manini et al. Frontiers in Neurology
- Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations
- (2022) Jerry R. Mendell et al. Molecular Therapy-Methods & Clinical Development
- Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
- (2022) Cedric Happi Mbakam et al. Frontiers in Medicine
- Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression
- (2022) Angelina M. Georgieva et al. Nature Communications
- Drug development progress in duchenne muscular dystrophy
- (2022) Jiexin Deng et al. Frontiers in Pharmacology
- Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
- (2022) Britt Hanson et al. Molecular Therapy-Nucleic Acids
- Phosphorylation alters the mechanical stiffness of a model fragment of the dystrophin homologue utrophin
- (2022) Maria Paz Ramirez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
- (2021) Anna Rugowska et al. Clinical Epigenetics
- Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy
- (2021) Rebecca J. Willcocks et al. JAMA Network Open
- Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
- (2021) Vratko Himič et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Efficient Correction of Duchenne Muscular Dystrophy Mutations by SpCas9 and Dual gRNAs
- (2021) Xi Xiang et al. Molecular Therapy-Nucleic Acids
- Duchenne muscular dystrophy
- (2021) Dongsheng Duan et al. Nature Reviews Disease Primers
- Concerns Regarding Therapeutic Implications of Very Low‐Level Dystrophin
- (2021) Eric P. Hoffman et al. ANNALS OF NEUROLOGY
- Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
- (2021) Alicja Starosta et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Casimersen: First Approval
- (2021) Matt Shirley DRUGS
- RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
- (2021) Zhichao Tang et al. MOLECULES
- Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
- (2021) Patricia Soblechero‐Martín et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength
- (2021) Paul T. Martin et al. PLoS One
- Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
- (2021) F. Chemello et al. Science Advances
- Full-length Dystrophin Restoration via Targeted Genomic Integration by AAV-CRISPR in a Humanized Mouse Model of Duchenne Muscular Dystrophy
- (2021) Adrian Pickar-Oliver et al. MOLECULAR THERAPY
- Safety, tolerability, and pharmacokinetics of casimersen in patients with D uchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial
- (2021) Kathryn R. Wagner et al. MUSCLE & NERVE
- Efficient precise in vivo base editing in adult dystrophic mice
- (2021) Li Xu et al. Nature Communications
- Dystrophin Dp71 Subisoforms Localize to the Mitochondria of Human Cells
- (2021) Emma Tabe Eko Niba et al. Life-Basel
- Gene Therapy for Duchenne Muscular Dystrophy
- (2021) Nertiyan Elangkovan et al. Journal of Neuromuscular Diseases
- Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases
- (2021) Yoshitsugu Aoki et al. Journal of Neuromuscular Diseases
- Life Expectancy in Duchenne Muscular Dystrophy
- (2021) Jonathan Broomfield et al. NEUROLOGY
- The Effect of Immunomodulatory Treatments on Anti-Dystrophin Immune Response After AAV Gene Therapy in Dystrophin Deficient mdx Mice
- (2021) Ning Li et al. Journal of Neuromuscular Diseases
- A Review of Deflazacort for Patients With Duchenne Muscular Dystrophy
- (2020) Mary Bylo et al. ANNALS OF PHARMACOTHERAPY
- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy
- (2020) Emanuele Loro et al. Scientific Reports
- Tissue-Specificity of Dystrophin–Actin Interactions: Isoform-Specific Thermodynamic Stability and Actin-Binding Function of Tandem Calponin-Homology Domains
- (2020) Vaibhav Upadhyay et al. ACS Omega
- Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
- (2020) Giuseppe Ronzitti et al. Frontiers in Immunology
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
- (2020) Salvatore Crisafulli et al. Orphanet Journal of Rare Diseases
- Dystrophin Dp71ab is monoclonally expressed in human satellite cells and enhances proliferation of myoblast cells
- (2020) Manal Farea et al. Scientific Reports
- Rapid, redox-mediated mechanical susceptibility of the cortical microtubule lattice in skeletal muscle
- (2020) D'anna M. Nelson et al. Redox Biology
- Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy
- (2020) Yvan Feraudy et al. ANNALS OF NEUROLOGY
- Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
- (2020) Kasturi Sengupta et al. Molecular Therapy-Nucleic Acids
- CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering
- (2020) Maryam Saifaldeen et al. Cells
- Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles
- (2020) Niclas E. Bengtsson et al. MOLECULAR THERAPY
- Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy
- (2019) Kay E. Davies et al. MOLECULAR THERAPY
- Development of Novel Micro-dystrophins with Enhanced Functionality
- (2019) Julian N. Ramos et al. MOLECULAR THERAPY
- The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
- (2019) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- Therapeutic developments for Duchenne muscular dystrophy
- (2019) Ingrid E. C. Verhaart et al. Nature Reviews Neurology
- In Situ Modification of Tissue Stem and Progenitor Cell Genomes
- (2019) Jill M. Goldstein et al. Cell Reports
- AAV-based gene therapies for the muscular dystrophies
- (2019) Julie M Crudele et al. HUMAN MOLECULAR GENETICS
- What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?
- (2019) Dominic J. Wells JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function
- (2019) Junling Zhao et al. MOLECULAR MEDICINE
- Immunogenicity of Cas9 Protein
- (2019) Aditi Mehta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- How the central domain of dystrophin acts to bridge F-actin to sarcolemmal lipids
- (2019) Dominique Mias-Lucquin et al. JOURNAL OF STRUCTURAL BIOLOGY
- Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models
- (2019) Yafeng Song et al. NATURE MEDICINE
- Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy
- (2019) Michael Naidoo et al. MOLECULAR NEUROBIOLOGY
- Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice
- (2019) Buel D. Rodgers et al. Molecular Therapy-Methods & Clinical Development
- Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice
- (2018) Cinzia Pisani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy
- (2018) Tatianna Wai Ying Wong et al. CURRENT GENE THERAPY
- Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
- (2018) Kelly J. Perkins et al. FEBS LETTERS
- Syntrophin binds directly to multiple spectrin-like repeats in dystrophin and mediates binding of nNOS to repeats 16–17
- (2018) Marvin E Adams et al. HUMAN MOLECULAR GENETICS
- Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics
- (2018) Justin R. Fallon et al. MATRIX BIOLOGY
- Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
- (2018) Seuk-Min Ryu et al. NATURE BIOTECHNOLOGY
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy
- (2018) Simon Guiraud et al. Expert Opinion on Orphan Drugs
- Human Dystrophin Structural Changes upon Binding to Anionic Membrane Lipids
- (2018) Raphael Dos Santos Morais et al. BIOPHYSICAL JOURNAL
- CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
- (2018) Benjamin L. Duchêne et al. MOLECULAR THERAPY
- Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy
- (2018) Peggy P. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- NS-065/NCNP-01: an Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy
- (2018) Naoki Watanabe et al. Molecular Therapy-Nucleic Acids
- Dystrophin As a Molecular Shock Absorber
- (2018) Shimin Le et al. ACS Nano
- CRISPR Correction of Duchenne Muscular Dystrophy
- (2018) Yi-Li Min et al. Annual Review of Medicine
- Perspective: Spectrin-Like Repeats in Dystrophin Have Unique Binding Preferences for Syntrophin Adaptors That Explain the Mystery of How nNOSμ Localizes to the Sarcolemma
- (2018) Justin M. Percival Frontiers in Physiology
- Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
- (2018) Tahnee L. Kennedy et al. Molecular Therapy-Methods & Clinical Development
- Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy
- (2017) Mikako Ito et al. HUMAN GENE THERAPY
- Normal and altered pre-mRNA processing in the DMD gene
- (2017) Sylvie Tuffery-Giraud et al. HUMAN GENETICS
- Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1
- (2017) Anna Majowicz et al. MOLECULAR THERAPY
- Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
- (2017) Leonela Amoasii et al. Science Translational Medicine
- Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
- (2017) Caroline Le Guiner et al. Nature Communications
- Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
- (2017) Niclas E. Bengtsson et al. Nature Communications
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction
- (2017) Manoj K. Mishra et al. PLoS One
- Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis
- (2017) Hung-Chih Chen et al. Scientific Reports
- Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
- (2016) Daria Wojtal et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
- (2016) Courtney S. Young et al. Cell Stem Cell
- Independent variability of microtubule perturbations associated with dystrophinopathy
- (2016) Joseph J. Belanto et al. HUMAN MOLECULAR GENETICS
- Dystrophin contains multiple independent membrane-binding domains
- (2016) Junling Zhao et al. HUMAN MOLECULAR GENETICS
- CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
- (2016) Li Xu et al. MOLECULAR THERAPY
- Histological effects of givinostat in boys with Duchenne muscular dystrophy
- (2016) Paolo Bettica et al. NEUROMUSCULAR DISORDERS
- Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
- (2016) Jean-Paul Iyombe-Engembe et al. Molecular Therapy-Nucleic Acids
- Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
- (2016) Ignazio Maggio et al. Scientific Reports
- Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
- (2015) Yingyin Liang et al. Bosnian Journal of Basic Medical Sciences
- Viral vector-mediated gene therapies
- (2015) Katrin Hollinger et al. CURRENT OPINION IN NEUROLOGY
- Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success—A Personal Perspective
- (2015) Eric Hastie et al. HUMAN GENE THERAPY
- Second-generation compound for the modulation of utrophin in the therapy of DMD
- (2015) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17
- (2015) Anne-Elisabeth Molza et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers
- (2015) Jon Tinsley et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
- (2015) Aurélie Goyenvalle et al. NATURE MEDICINE
- Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division
- (2015) Nicolas A Dumont et al. NATURE MEDICINE
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- I-TASSER server: new development for protein structure and function predictions
- (2015) Jianyi Yang et al. NUCLEIC ACIDS RESEARCH
- Abnormal splicing switch of DMD’s penultimate exon compromises muscle fibre maintenance in myotonic dystrophy
- (2015) Frédérique Rau et al. Nature Communications
- Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
- (2015) David G. Ousterout et al. Nature Communications
- Gene therapy for Duchenne muscular dystrophy
- (2015) Julian Ramos et al. Expert Opinion on Orphan Drugs
- Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
- (2015) Hongmei Lisa Li et al. Stem Cell Reports
- Nucleocytoplasmic shuttling of the Duchenne muscular dystrophy gene product dystrophin Dp71d is dependent on the importin α/β and CRM1 nuclear transporters and microtubule motor dynein
- (2014) R. Suárez-Sánchez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Ataluren: First Global Approval
- (2014) Nicola J. Ryan DRUGS
- Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting
- (2014) Kristy Swiderski et al. HUMAN MOLECULAR GENETICS
- The role of nNOS and PGC-1 in skeletal muscle cells
- (2014) S. Baldelli et al. JOURNAL OF CELL SCIENCE
- Dystrobrevin increases dystrophin's binding to the dystrophin–glycoprotein complex and provides protection during cardiac stress
- (2014) Jana Strakova et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- (2014) Katharine Bushby et al. MUSCLE & NERVE
- Microtubule binding distinguishes dystrophin from utrophin
- (2014) J. J. Belanto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
- (2014) C. Long et al. SCIENCE
- Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
- (2014) Yusuke Echigoya et al. Nucleic Acid Therapeutics
- Adeno-associated viral vectors do not efficiently target muscle satellite cells
- (2014) Andrea LH Arnett et al. Molecular Therapy-Methods & Clinical Development
- Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice
- (2013) Maaike van Putten et al. FASEB JOURNAL
- Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates
- (2013) Louis G. Chicoine et al. MOLECULAR THERAPY
- Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
- (2013) LG Chicoine et al. MOLECULAR THERAPY
- Cas9 as a versatile tool for engineering biology
- (2013) Prashant Mali et al. NATURE METHODS
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
- (2013) Rebecca J. Fairclough et al. NATURE REVIEWS GENETICS
- Identification of New Dystroglycan Complexes in Skeletal Muscle
- (2013) Eric K. Johnson et al. PLoS One
- Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
- (2013) Richard S. Finkel et al. PLoS One
- Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness
- (2012) Joe Sarkis et al. FASEB JOURNAL
- Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse
- (2012) Gaynor Miller et al. HUMAN MOLECULAR GENETICS
- The Shortest Isoform of Dystrophin (Dp40) Interacts with a Group of Presynaptic Proteins to Form a Presumptive Novel Complex in the Mouse Brain
- (2012) Takenori Tozawa et al. MOLECULAR NEUROBIOLOGY
- Nitric oxide synthases: regulation and function
- (2011) U. Forstermann et al. EUROPEAN HEART JOURNAL
- Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice
- (2011) Luke M. Judge et al. HUMAN MOLECULAR GENETICS
- The Role of Alpha-Dystrobrevin in Striated Muscle
- (2011) Masayuki Nakamori et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical progression of X-linked muscular dystrophy in two German Shorthaired Pointers
- (2011) Natasha J. Olby et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
- (2011) Brian Bostick et al. MOLECULAR THERAPY
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
- (2011) Dawn E Bowles et al. MOLECULAR THERAPY
- Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
- (2011) Jonathon M. Tinsley et al. PLoS One
- Ankyrin-B Interactions with Spectrin and Dynactin-4 Are Required for Dystrophin-based Protection of Skeletal Muscle from Exercise Injury
- (2010) Gai Ayalon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dystrophins, Utrophins, and Associated Scaffolding Complexes: Role in Mammalian Brain and Implications for Therapeutic Strategies
- (2010) Caroline Perronnet et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin
- (2010) D. Li et al. JOURNAL OF CELL SCIENCE
- Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6
- (2010) Guy L Odom et al. MOLECULAR THERAPY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice
- (2010) A. R. Amenta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins
- (2010) Glen B. Banks et al. PLoS Genetics
- The neurobiology of the dystrophin-associated glycoprotein complex
- (2009) Adrian Waite et al. ANNALS OF MEDICINE
- The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b
- (2009) Kazunari Yamashita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice
- (2009) Maria Grazia Di Certo et al. HUMAN MOLECULAR GENETICS
- Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
- (2009) Yi Lai et al. JOURNAL OF CLINICAL INVESTIGATION
- The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin
- (2009) Jung Hae Yoon et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan
- (2008) Gai Ayalon et al. CELL
- Deregulated Protein Kinase A Signaling and Myospryn Expression in Muscular Dystrophy
- (2008) Joseph G. Reynolds et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Microutrophin Delivery Through rAAV6 Increases Lifespan and Improves Muscle Function in Dystrophic Dystrophin/Utrophin-deficient Mice
- (2008) Guy L Odom et al. MOLECULAR THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started